Company: INMB
Filing Date: 2025-03-07
Form Type: 424B5
Source: 0001213900-25-021719
Chunk: 23

Company: Inmune Bio, Inc.
Filing Date: 2025-03-07
Form: 424B5
Chunk 23
---
uable upon such exercise
to the account of the warrant holders. The estimated offering expenses payable by us will be approximately $5,000, which includes
legal and other fees associated with registering and issuing the common stock. After our estimated offering expenses, we expect the
net proceeds from this offering to be approximately $29.9 million, assuming all of the Warrants are exercised for cash. It is possible that
not all of the securities we are offering pursuant to this prospectus supplement will be sold, in which case our net proceeds would
be reduced.

Electronic Distribution

A prospectus supplement in
electronic format is available on the website maintained by the SEC at sec.gov. Other than the prospectus supplement and the accompanying
prospectus in electronic format, any information contained in any other website is not part of this prospectus supplement or the registration
statement of which this prospectus supplement and accompanying prospectus form a part, has not been approved and/or endorsed by us and
should not be relied upon by investors.

<div align='center'>LEGAL MATTERS</div>

The validity of the issuance
of the securities offered by this prospectus will be passed upon for us by Sichenzia Ross Ference Carmel LLP, New York, New York.

<div align='center'>EXPERTS</div>

The consolidated financial statements of INmune
Bio Inc. as of and for the years ended December 31, 2023 and 2022 appearing in INmune Bio Inc.’s Annual Report on Form 10-K for
the year ended December 31, 2023 have been audited by Marcum LLP, as set forth in its report thereon, which includes an explanatory paragraph
as to the Company’s ability to continue as a going concern, included therein, and incorporated herein by reference. Such consolidated
financial statements are incorporated herein by reference in reliance upon such report given on the authority of such firm as experts
in accounting and auditing.

<div align='center'>WHERE YOU CAN FIND MORE INFORMATION</div>

We file annual, quarterly
and special reports, along with other information with the SEC. The SEC maintains an Internet site that contains reports, proxy and information
statements, and other information regarding issuers that file electronically with the SEC. Our SEC filings are available to the public
over the Internet at the SEC’s website at http://www.sec.gov.

This prospectus is part of
a registration statement on Form S-3 that we filed with the SEC to register the securities